Bellevue Group’s Insmed INSM Stock Holding History

Bellevue Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$8.19M	Sell	81,397 -69,153	-46%	-$6.96M	0.18%	70
2025 Q1	$11.5M	Sell	150,550 -107,933	-42%	-$8.23M	0.26%	70
2024 Q4	$17.8M	Sell	258,483 -266,951	-51%	-$18.4M	0.34%	67
2024 Q3	$38.4M	Sell	525,434 -496,266	-49%	-$36.2M	0.62%	45
2024 Q2	$68.5M	Sell	1,021,700 -1,120,143	-52%	-$75M	1.11%	23
2024 Q1	$58.1M	Sell	2,141,843 -149,115	-7%	-$4.05M	0.89%	31
2023 Q4	$71M	Sell	2,290,958 -871,777	-28%	-$27M	1.09%	28
2023 Q3	$79.9M	Sell	3,162,735 -138,176	-4%	-$3.49M	1.29%	19
2023 Q2	$69.6M	Buy	3,300,911 +7,809	+0.2%	+$165K	0.99%	30
2023 Q1	$56.1M	Buy	3,293,102 +15,895	+0.5%	+$271K	0.81%	43
2022 Q4	$65.5M	Buy	3,277,207 +62,503	+2%	+$1.25M	0.87%	34
2022 Q3	$69.2M	Sell	3,214,704 -406,858	-11%	-$8.76M	0.99%	35
2022 Q2	$71.4M	Buy	3,621,562 +69,786	+2%	+$1.38M	1.01%	31
2022 Q1	$83.5M	Buy	3,551,776 +30,915	+0.9%	+$727K	0.97%	37
2021 Q4	$95.9M	Buy	3,520,861 +135,216	+4%	+$3.68M	0.99%	35
2021 Q3	$93.2M	Buy	3,385,645 +264,744	+8%	+$7.29M	0.95%	39
2021 Q2	$88.8M	Buy	3,120,901 +643,735	+26%	+$18.3M	0.87%	40
2021 Q1	$84.4M	Buy	2,477,166 +860,166	+53%	+$29.3M	0.89%	36
2020 Q4	$53.8M	Buy	1,617,000 +396,831	+33%	+$13.2M	0.62%	51
2020 Q3	$39.2M	Sell	1,220,169 -236,005	-16%	-$7.59M	0.54%	53
2020 Q2	$40.1M	Sell	1,456,174 -157,296	-10%	-$4.33M	0.57%	47
2020 Q1	$25.9M	Buy	1,613,470 +29,910	+2%	+$479K	0.5%	52
2019 Q4	$37.8M	Buy	1,583,560 +392,080	+33%	+$9.36M	0.6%	43
2019 Q3	$21M	Buy	1,191,480 +571,021	+92%	+$10.1M	0.39%	56
2019 Q2	$15.9M	Sell	620,459 -38,975	-6%	-$998K	0.27%	64
2019 Q1	$19.2M	Sell	659,434 -149,712	-19%	-$4.35M	1.05%	29
2018 Q4	$10.6M	Buy	809,146 +242,845	+43%	+$3.19M	0.7%	41
2018 Q3	$11.5M	Buy	566,301 +142,250	+34%	+$2.88M	0.73%	46
2018 Q2	$10M	Buy	424,051 +89,562	+27%	+$2.12M	0.86%	44
2018 Q1	$7.53M	Buy	+334,489	New	+$7.53M	0.75%	50